Supplemental material
Open access
293
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study
Kyung-Sang Yua Seoul National University College of Medicine and Hospital, Seoul, Republic of Koreahttps://orcid.org/0000-0003-0921-7225View further author information
, Hyunwook Ryua Seoul National University College of Medicine and Hospital, Seoul, Republic of Koreahttps://orcid.org/0009-0004-5078-770XView further author information
, Dongseong Shinb Gachon University Gil Medical Center, Incheon, Republic of Koreahttps://orcid.org/0000-0002-4227-374XView further author information
, MinKyu Parkc Chungbuk National University College of Medicine and Hospital, Cheongju, Republic of Koreahttps://orcid.org/0000-0002-9851-7555View further author information
, JunGi Hwangc Chungbuk National University College of Medicine and Hospital, Cheongju, Republic of Koreahttps://orcid.org/0000-0002-0965-0531View further author information
, Seol Ju Moond Jeonbuk National University College of Medicine and Hospital, Jeonbuk, Republic of Koreahttps://orcid.org/0000-0001-6484-2029View further author information
, Min-Gul Kimd Jeonbuk National University College of Medicine and Hospital, Jeonbuk, Republic of Koreahttps://orcid.org/0000-0001-7269-9533View further author information
, Edward Keystonee University of Toronto, Toronto, Ontario, Canadahttps://orcid.org/0000-0001-6606-0071View further author information
, Josef S Smolenf Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austriahttps://orcid.org/0000-0002-4302-8877View further author information
, SungHyun Kimg Celltrion, Inc., Incheon, Republic of KoreaView further author information
, YunJu Baeg Celltrion, Inc., Incheon, Republic of KoreaView further author information
, DaBee Jeong Celltrion, Inc., Incheon, Republic of KoreaView further author information
, JiYoung Jangg Celltrion, Inc., Incheon, Republic of KoreaView further author information
, GoEun Yangg Celltrion, Inc., Incheon, Republic of KoreaView further author information
, JiHun Baeg Celltrion, Inc., Incheon, Republic of KoreaView further author information
, JaeYong Leeg Celltrion, Inc., Incheon, Republic of KoreaView further author information
& Gerd R Burmesterh Charité – UniversitätsmedizinBerlin, Berlin, GermanyCorrespondence[email protected]
View further author information
show allView further author information
Received 09 Nov 2023, Accepted 15 Feb 2024, Published online: 21 Jun 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.